Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/14/2005EP1574512A1 Polymorphic and other crystalline forms of cis-FTC
09/14/2005EP1574504A1 Benzomorpholine derivatives
09/14/2005EP1574503A1 Novel 2,4-diamino-1,3,5-triazine derivative
09/14/2005EP1574501A1 Quinolinone derivatives, pharmaceutical compositions containing them and their use
09/14/2005EP1574500A1 Quinoline derivative as diagnostic probe for disease with tau protein accumulation
09/14/2005EP1574499A1 Inhibitors of DNA methylation in tumor cells
09/14/2005EP1574222A1 Sterilization process
09/14/2005EP1574221A1 Stable injectable diclofenac compositions
09/14/2005EP1574220A1 Light-blocking agent and film-forming composition
09/14/2005EP1574218A1 A medicament containing epidemium extract for treatment of prostatic hyperplasia and prostatitis
09/14/2005EP1574215A1 Solid drug for oral use
09/14/2005EP1574214A1 Pharmaceutical composition comprising fenofibrate and process for its preparation
09/14/2005EP1574213A1 Use of histone deacetylase inhibitors for increasing therapeutic gain in radiotherapy and chemotherapy
09/14/2005EP1574212A1 Prevention and treatment of androgen-deprivation induced hot flashes, decreased lean muscle mass, loss of libido or erectile dysfunction
09/14/2005EP1574211A1 Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
09/14/2005EP1574209A1 Device and method for treating ophthalmic diseases
09/14/2005EP1574202A2 Hair mousse with long-lasting effect
09/14/2005EP1574201A1 Composition of an external dermatological agent
09/14/2005EP1573450A2 System and method for transparent early detection, warning, and intervention during a medical procedure
09/14/2005EP1573045A2 Heart failure gene determination and therapeutic screening
09/14/2005EP1573039A2 Compositions and methods for diagnosing and treating mood disorders
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
09/14/2005EP1572963A2 Carbohydrate-based synthetic vaccines for hiv
09/14/2005EP1572952A2 Novel polynucleotide and polypeptide sequences and uses thereof
09/14/2005EP1572945A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572935A2 Methods of making hypermutable cells using pmsr homologs
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
09/14/2005EP1572885A2 Methods for treating diabetes and other blood sugar disorders
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572715A1 Steroid compounds with anti-tumor activity
09/14/2005EP1572711A1 Anhydrous crystalline azido cytosine hemisulfate derivative
09/14/2005EP1572710A2 Antiviral nucleoside derivatives
09/14/2005EP1572708A1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
09/14/2005EP1572707A1 Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
09/14/2005EP1572705A2 Sugar modified nucleosides as viral replication inhibitors
09/14/2005EP1572700A1 Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof
09/14/2005EP1572698A1 3-substituted 3,4-dihydro-thieno[2,3-d]pyrimidine-4-one-derivatives, production and use thereof
09/14/2005EP1572694A1 Pyrrolo'2,1-c!'1,4! benzodiazepines as vasopressin agonists
09/14/2005EP1572693A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
09/14/2005EP1572691A1 Pyrazole compounds as integrin receptor antagonists derivatives
09/14/2005EP1572685A1 Substituted benzodioxepins
09/14/2005EP1572682A2 Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
09/14/2005EP1572676A2 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process
09/14/2005EP1572672A1 Benzoxazocines and their use as monoamine-reuptake inhibitors
09/14/2005EP1572666A1 3h-quinazolin-4-one derivatives
09/14/2005EP1572665A2 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors
09/14/2005EP1572664A1 Pyrazole compounds
09/14/2005EP1572659A2 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence
09/14/2005EP1572658A1 The use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572650A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572643A2 Crystalline form f of atorvastatin hemi-calcium salt
09/14/2005EP1572638A2 An improved process for the preparation of amorphous atorvastatin calcium salt (2:1)
09/14/2005EP1572632A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
09/14/2005EP1572630A1 Antibacterial agents
09/14/2005EP1572626A1 Therapeutic agents
09/14/2005EP1572625A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
09/14/2005EP1572622A1 Levalbuterol salt
09/14/2005EP1572339A2 Biodegradable polyurethane/urea compositions
09/14/2005EP1572300A1 Combination for the treatment of adhd
09/14/2005EP1572299A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
09/14/2005EP1572240A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005EP1572237A1 Combinations of vanilloid antagonist and nsaid for the treatment of pain
09/14/2005EP1572219A1 Efficient method for producing compositions enriched in total phenols
09/14/2005EP1572218A2 Ester combination local anesthetic
09/14/2005EP1572217A1 Combination medicament
09/14/2005EP1572216A1 Steroid compositions for intraocular use
09/14/2005EP1572213A1 Method of treatment of transplant rejection
09/14/2005EP1572212A2 Quinoline compounds for use in mch receptor related disorders
09/14/2005EP1572211A1 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines
09/14/2005EP1572209A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
09/14/2005EP1572208A2 Method for counteracting a pathologic change in the beta-adrenergic pathway
09/14/2005EP1572206A2 Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines
09/14/2005EP1572205A2 Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds
09/14/2005EP1572203A1 Substituted 4-alkoxyoxazol derivatives as ppar agonists
09/14/2005EP1572202A2 Use of serotonin receptor antagonists for the treatment of sleep apnea
09/14/2005EP1572201A1 Pharmaceutical compositions of sertaconazole for vaginal use
09/14/2005EP1572200A1 Aminoindazole derivatives and use thereof as kinase inhibitors
09/14/2005EP1572199A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
09/14/2005EP1572197A1 4- 1- (sulfonyl) -1h-indol-2-yl)-4- (hydroxy) -cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents
09/14/2005EP1572196A1 Combination of a dpp-iv inhibitor and a ppar-alpha compound
09/14/2005EP1572195A2 Natural vitamin e compositions with superior antioxidant potency
09/14/2005EP1572194A1 Anti-cancer composition comprising dmxaa or related compound
09/14/2005EP1572193A1 Microtubule stabilisers for treating stenosis in stents
09/14/2005EP1572192A1 Controlled release preparations comprising tramadol and topiramate
09/14/2005EP1572191A1 Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings
09/14/2005EP1572190A1 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
09/14/2005EP1572189A1 Method of lowering crp and reducing systemic inflammation
09/14/2005EP1572188A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders
09/14/2005EP1572187A1 Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
09/14/2005EP1572186A2 Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents
09/14/2005EP1572185A1 Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents
09/14/2005EP1572184A1 Gabapentin analogues for fibromyalgia and other related disorders
09/14/2005EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction
09/14/2005EP1572182A1 Composition for the treatment of gastrointestinal disorders
1 ... 4543 4544 4545 4546 4547 4548 4549 4550 4551 4552 4553 4554 4555 4556 4557 4558 4559 4560 4561 4562 4563 ... 7860